Papillorenal syndrome secondary prevention: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Management of the disease should be focused on preventing | Management of the disease should be focused on preventing [[End-stage renal disease]] (ESRD) and/or [[vision]] loss. The treatment of [[hypertension]] may also preserve [[renal]] function. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Management of the disease should be focused on preventing | Management of the disease should be focused on preventing [[End-stage renal disease]] (ESRD) and/or [[vision]] loss. The treatment of [[hypertension]] may also preserve [[renal]] function. [[Renal]] replacement therapy is recommended, and [[vision]] experts may provide assistance to adapt to continued vision loss.<ref name="ncbi">{{cite journal |author=Pagon RA, Bird TD, Dolan CR, ''et al.'' |title= |journal= |volume= |issue= |pages= |year= |pmid=20301624 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 16:46, 30 September 2020
|
Papillorenal syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Papillorenal syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Papillorenal syndrome secondary prevention |
|
Risk calculators and risk factors for Papillorenal syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Management of the disease should be focused on preventing End-stage renal disease (ESRD) and/or vision loss. The treatment of hypertension may also preserve renal function.
Secondary Prevention
Management of the disease should be focused on preventing End-stage renal disease (ESRD) and/or vision loss. The treatment of hypertension may also preserve renal function. Renal replacement therapy is recommended, and vision experts may provide assistance to adapt to continued vision loss.[1]